HAYA Therapeutics ^None

HAYA Therapeutics is a precision therapeutics company that develops RNA-based therapeutics to treat heart failure and other serious health conditions associated with aging, including cancer. The company's therapeutics utilize biopharmaceutical therapy to target a heart-specific regulator of fibrosis, the long noncoding RNA, to block myocardial fibrosis and treat heart failure. HAYA Therapeutics also develops programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases.